Rayhan A Lal
Overview
Explore the profile of Rayhan A Lal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomson E, Lee S, Xu H, Moeller H, Sands J, Lal R, et al.
Diabetes
. 2025 Mar;
PMID: 40029687
Cadaveric islet and stem cell-derived transplantation hold promise as treatments for type 1 diabetes (T1D). To tackle the issue of immunocompatibility, numerous cellular macroencapsulation techniques that utilize diffusion to transport...
2.
Walker A, Haller M, Addala A, Filipp S, Lal R, Gurka M, et al.
Diabetes Care
. 2024 Dec;
48(2):243-250.
PMID: 39688288
Objective: The Project Extension for Community Healthcare Outcomes (ECHO) model is used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach. Few studies have rigorously...
3.
Hughes M, Pasquel F, Davis G, Lal R, Buckingham B, Boughton C, et al.
Diabetes Technol Ther
. 2024 Dec;
PMID: 39618315
The introduction of automated insulin delivery (AID) systems represents a significant advancement in diabetes care, offering substantial benefits in outpatient settings. Although clinical studies suggest that these systems can also...
4.
Shah V, Peters A, Umpierrez G, Sherr J, Akturk H, Aleppo G, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):191-216.
PMID: 39517127
With increasing prevalence of obesity and cardiovascular diseases, there is a growing interest in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as an adjunct therapy in type 1 diabetes...
5.
Renard E, Weinstock R, Aleppo G, Bode B, Brown S, Castorino K, et al.
Diabetes Care
. 2024 Oct;
47(12):2248-2257.
PMID: 39423118
Objective: To examine the efficacy and safety of the tubeless Omnipod 5 automated insulin delivery (AID) system compared with pump therapy with a continuous glucose monitor (CGM) in adults with...
6.
Kim J, Chen M, Rezaei S, Liang A, Seav S, Onyeka S, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2438535.
PMID: 39412810
No abstract available.
7.
Klonoff D, Freckmann G, Pleus S, Kovatchev B, Kerr D, Tse C, et al.
J Diabetes Sci Technol
. 2024 Oct;
18(6):1346-1361.
PMID: 39369312
Introduction: An error grid compares measured versus reference glucose concentrations to assign clinical risk values to observed errors. Widely used error grids for blood glucose monitors (BGMs) have limited value...
8.
Riddell M, Lewis D, Turner L, Lal R, Shahid A, Zaharieva D
J Diabetes Sci Technol
. 2024 Aug;
:19322968241267820.
PMID: 39143692
Automated insulin delivery (AID) systems enhance glucose management by lowering mean glucose level, reducing hyperglycemia, and minimizing hypoglycemia. One feature of most AID systems is that they allow the user...
9.
Lee M, Seav S, Ongwela L, Lee J, Aubyrn R, Cao F, et al.
Diabetes Care
. 2024 Aug;
47(10):1838-1845.
PMID: 39140891
Objective: We aimed to assess the feasibility, clinical accuracy, and acceptance of a hospital-wide continuous glucose monitoring (CGM) policy with electronic health record (EHR)-integrated validation for insulin dosing. Research Design...
10.
Blanco L, Wilcox J, Hughes M, Lal R
J Diabetes Sci Technol
. 2024 Apr;
18(6):1313-1323.
PMID: 38654491
Background: Continuous subcutaneous insulin infusion (CSII) is a common treatment option for people with diabetes (PWD), but insulin infusion failures pose a significant challenge, leading to hyperglycemia, diabetes burnout, and...